Evidence map›Paper›PMID 37457702›Full record

ArticleFrontiers in immunology2023

Immunogenicity and protective efficacy of nanoparticle formulations of L-SseB against

Sayan Das, Debaki R Howlader, Ti Lu, Sean K Whittier, Gang Hu, Simran Sharma, Zackary K Dietz, Siva S K Ratnakaram, David J Varisco, Robert K Ernst and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Sayan DasDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States.
Debaki R HowladerDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States.
Ti LuDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States.
Sean K WhittierDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States.
Gang HuDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States.
Simran SharmaDepartment of Veterinary Pathobiology and Bond Life Science Center, University of Missouri, Columbia, MO, United States.
Zackary K DietzDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States.
Siva S K RatnakaramDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States.
David J VariscoDepartment of Microbial Pathogenesis, University of Maryland, Baltimore, MD, United States.
Robert K ErnstDepartment of Microbial Pathogenesis, University of Maryland, Baltimore, MD, United States.
William D PickingDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States.
Wendy L PickingDepartment of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, United States.
University of Kansas · USUniversity of Maryland, Baltimore · USMissouri College · US

Funding

Vaccines to counter emerging antibiotic resistance (R01AI138970)R01AI138970 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI PICKING, WENDY L. · 2018 to 2022
$6.0M
NIAID NIH HHS HHSN272201800043CNIAID NIH HHS R01 AI138970
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Salmonella entericaSalmonella InfectionsTyphoid FeverTyphoid-Paratyphoid VaccinesAnimalsEscherichia coliHumansMiceRabbitsTyphoid-Paratyphoid VaccinesformulationIL-17SalmonellaT3SStyphoidvaccine

Identifiers

PMID37457702
PMCPMC10347375
OpenAlexW4382790978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.